Print PDF

Sheppard Mullin Advises CoreRx in Sale to NovaQuest Private Equity


Sheppard Mullin represented CoreRx, Inc., a global provider of clinical and commercial contract development and manufacturing organization (CDMO) services to a wide range of small to mid-sized pharmaceutical and biotech clients, in its sale to NovaQuest Private Equity, a leading investor in technology and services companies in the life sciences and healthcare sectors.

The Sheppard Mullin deal team was led by partner Shon Glusky and included special counsel Jeff Taylor and associate David Rostowsky.  Invaluable assistance was provided by partner Evan Williams, Keith Gercken, Robert Guite, Olivier Theard, Allison Fulton, Kevin Ryan, Dmitriy Chelnitsky, Leo Caseria, and Jim Gatto, associates John Crisp and Ethan Aronson, and attorney Christina Nguyen.

Click here to read the press release.

Practice Areas


Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.